Charles W. Newton

LYEL

Charles W. Newton serves as director at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$111.6K

Total Sells

2 trades

$20.8K

Net Position

Net Buyer

$90.8K

Companies Traded

KROS, LYEL

Active Period

Mar 2025 – Jun 2026

3 total trades

Most Recent

Sell KROS

Jun 15, 2026 · $5.5K

Charles W. Newton's Insider Trading at Lyell Immunopharma, Inc. (LYEL)

Buys

1 · $111.6K

Sells

1 · $15.3K

Total Shares Bought

200,000

Total Shares Sold

1,453

LYEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 20, 2025	Sell	1,453	$10.54	$15.3K	0
Mar 17, 2025	Buy	200,000	$0.56	$111.6K	0

Charles W. Newton's Insider Trading at Keros Therapeutics, Inc. (KROS)

Buys

0 · $0.00

Sells

1 · $5.5K

Total Shares Bought

Total Shares Sold

550

KROS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 15, 2026	Sell	550	$10.04	$5.5K	12,665

Related Insiders

BIENAIME JEAN JACQUES

director

KROSBuy · Jun 17, 2026

Lynn Seely

President and CEO

LYELSell · Jun 15, 2026

Stephen J. Hill

officer: Chief Operating Officer

LYELSell · Jun 15, 2026

Veronica Sanchez Bulis

VP, Corporate Controller

LYELSell · Jun 15, 2026

Gary K. Lee

officer: Chief Scientific Officer

LYELSell · Jun 15, 2026

David Shook

officer: Chief Medical Officer

LYELSell · Jun 11, 2026

Nima Farzan

director

KROSSell · Jun 8, 2026

Julius Knowles

director

KROSSell · Jun 8, 2026

Explore More Insider Trading Data

LYEL Insider Trading Activity

View all insider trades at Lyell Immunopharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity